VuEssence is a development-stage company focused on creating innovative solutions for aiding in the diagnoses and treatment of conditions related to stroke and other neurological injuries. In spite of making strides in recognizing the early signs of stroke and managing conditions that increase risk for the disease, stroke remains as a leading cause of death and disability in the US and worldwide. Recent advances in understanding the human genome and transcriptome have created opportunities for new approaches to diagnosing, managing and treating disease. The Company is utilizing advanced molecular analysis technologies to develop specialized diagnostic devices that will be able to help in the detection and management of stroke and related conditions.